Internist's view on skin manifestations of hyperlipidemia in diabetic patients;Kožní projevy hyperlipidemie u diabetiků z pohledu internisty

Vnitrni Lekarstvi

Volumn 52, Issue 5, 2006, Pages 465-469

  Zadák, Zdeněk ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Continual plasmapheresis; Hyperlipoproteinemia; Hyperlipoproteinemic crisis; Metabolic syndrome; Xanthelasma

Indexed keywords

ATORVASTATIN; FIBRIC ACID DERIVATIVE;

ATHEROMA; CONFERENCE PAPER; DIABETES MELLITUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIVER DYSFUNCTION; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMAPHERESIS; SKIN MANIFESTATION; XANTHOMA; ARTICLE; EYELID DISEASE; PATHOLOGY; SKIN DISEASE; XANTHOMATOSIS;

DIABETES COMPLICATIONS; EYELID DISEASES; HUMANS; HYPERLIPIDEMIAS; PLASMAPHERESIS; SKIN DISEASES; XANTHOMATOSIS;

EID: 33744918077     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Frankel RM, Capone R. Xanthelasmas and xanthomas - cutaneous clues to systemic lipid disorders. Clinical Eye and Vision Care 1995; 7: 117-128.
2. Ribera M, Pinto X, Argimon JM et al. Lipid Metabolism and Apolipoprotein E Phenotypes in Patients With Xanthelasma. The American Journal of Medicine 1995; 99: 485-490.
3. Bhatnagar D. Hypertriglyceridaemia. In: Betteridge DJ, Illingworth DR, Shepard J. Lipoproteins in health and disease. New York: Oxford University Press 1999.
4. Zadák Z, Tichý M, Mělka O. Vliv chylozity séra na výsledky některých biochemických vyšetření. Biochem Clin Bohemoslov 1987; 16: 251-259.
5. Zadák Z, Tichý M. Hyperlipidemia and monoclonal gammapathy. Neoplasma 1987; 34: 169-172.
6. Zadák Z, Vaňásek J, Bláha M et al. Treatment of hyperlipoproteinaemias using plasma exchange. Hradec Králové: Sborník vědeckých prací LF UK Hradec Králové 1982; 25: 45-73.